Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/90816
DC FieldValueLanguage
dc.contributor.authorSimões, Ana-
dc.contributor.authorVeiga, Francisco-
dc.contributor.authorVitorino, Carla-
dc.date.accessioned2020-09-08T15:54:47Z-
dc.date.available2020-09-08T15:54:47Z-
dc.date.issued2020-07-09-
dc.identifier.issn1999-4923pt
dc.identifier.urihttps://hdl.handle.net/10316/90816-
dc.description.abstractThis work aims at providing the assumptions to assist the sustainable development of cream formulations. Specifically, it envisions to rationalize and predict the effect of formulation and process variability on a 1% hydrocortisone cream quality profile, interplaying microstructure properties with product performance and stability. This tripartite analysis was supported by a Quality by Design approach, considering a three-factor, three-level Box-Behnken design. Critical material attributes and process parameters were identified from a failure mode, effects, and criticality analysis. The impact of glycerol monostearate amount, isopropyl myristate amount, and homogenization rate on relevant quality attributes was estimated crosswise. The significant variability in product droplet size, viscosity, thixotropic behavior, and viscoelastic properties demonstrated a noteworthy influence on hydrocortisone release profile (112±2-196±7 μg/cm2/√h) and permeation behavior (0.16±0.03-0.97±0.08 μg/cm2/h), and on the assay, instability index and creaming rate, with values ranging from 81.9 to 120.5%, 0.031±0.012 to 0.28±0.13 and from 0.009±0.000 to 0.38±0.07 μm/s, respectively. The release patterns were not straightforwardly correlated with the permeation behavior. Monitoring the microstructural parameters, through the balanced adjustment of formulation and process variables, is herein highlighted as the key enabler to predict cream performance and stability. Finally, based on quality targets and response constraints, optimal working conditions were successfully attained through the establishment of a design space.pt
dc.language.isoengpt
dc.publisherMDPIpt
dc.relationUIDB/50006/2020pt
dc.relationUID/QUI/00313/2020pt
dc.rightsopenAccesspt
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt
dc.subjectBox–Behnken designpt
dc.subjectCream formulationpt
dc.subjectMicrostructurept
dc.subjectPerformancept
dc.subjectQuality by designpt
dc.subjectRheologypt
dc.subjectTopical dermatological productpt
dc.titleProgressing Towards the Sustainable Development of Cream Formulationspt
dc.typearticle-
degois.publication.firstPage647pt
degois.publication.issue7pt
degois.publication.titlePharmaceuticspt
dc.relation.publisherversionhttps://www.mdpi.com/1999-4923/12/7/647pt
dc.peerreviewedyespt
dc.identifier.doi10.3390/pharmaceutics12070647pt
degois.publication.volume12pt
dc.date.embargo2020-07-09*
uc.date.periodoEmbargo0pt
item.grantfulltextopen-
item.fulltextCom Texto completo-
item.openairetypearticle-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.researchunitCQC - Coimbra Chemistry Centre-
crisitem.author.parentresearchunitFaculty of Sciences and Technology-
crisitem.author.orcid0000-0002-1041-0068-
crisitem.author.orcid0000-0003-3424-548X-
Appears in Collections:I&D CQC - Artigos em Revistas Internacionais
Files in This Item:
File Description SizeFormat
Pharmaceutics.pdf4.54 MBAdobe PDFView/Open
Show simple item record

SCOPUSTM   
Citations

8
checked on Nov 9, 2022

WEB OF SCIENCETM
Citations 20

7
checked on May 2, 2023

Page view(s)

182
checked on Apr 24, 2024

Download(s)

117
checked on Apr 24, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons